Experiences of Patients After Withdrawal From Cancer Clinical Trials

Area of Science:

• Oncology
• Clinical Trials
• Patient Experience Research

Background:

• Cancer clinical trials (CCTs) offer experimental treatments but little is known about patient withdrawal experiences.
• Understanding patient perspectives is vital for improving CCT participation and care.
• Withdrawal from CCTs can be a critical juncture for patients facing limited options.

Purpose of the Study:

• To examine the experiences of patient-participants during their withdrawal from cancer clinical trials.
• To identify key themes and challenges faced by patients exiting CCTs.

Main Methods:

• A qualitative, descriptive study utilizing semistructured interviews with 20 former CCT participants.
• Interviews were conducted at a National Cancer Institute-designated comprehensive cancer center.
• Data were analyzed using qualitative software to identify emergent themes.

Main Results:

• Five main themes emerged: posttrial prognostic awareness, goals of care discussions, emotional coping, burden of adverse effects, and professional trust/support.
• Participants frequently reported limited discussions about immediate posttrial care needs, leading to uncertainty.
• Common reasons for withdrawal included disease progression and adverse effects.

Conclusions:

• Patient-participants exiting CCTs often experience intense symptoms, emotions, and awareness of limited lifespan.
• Enhanced communication addressing posttrial needs throughout the CCT is essential for patient navigation.
• Future research should focus on responsible and ethical CCT transition components, including timely discussions with patients and families.